DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells

Cancer Research

Volumn 73, Issue 2, 2013, Pages 785-791

  Lee, Jin Hyup ^a   Gaddameedhi, Shobhan ^a   Ozturk, Nuri ^a   Ye, Rui ^a   Sancar, Aziz ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOCHROME 1; CRYPTOCHROME 2; DOXORUBICIN; EARLY GROWTH RESPONSE FACTOR 1; OXALIPLATIN; PROTEIN P53; RAS PROTEIN; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL TRANSFORMATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; CRY1 GENE; CRY2 GENE; DNA ALKYLATION; DNA CROSS LINKING; DNA DAMAGE; DNA PROTEIN COMPLEX; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; FEEDBACK SYSTEM; FIBROBLAST; GENE; GENE MUTATION; GENOTOXICITY; MOUSE; NONHUMAN; P53 GENE; P73 GENE; PRIORITY JOURNAL; SKIN; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; UPREGULATION;

ANIMALS; CELL DEATH; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CIRCADIAN RHYTHM; CRYPTOCHROMES; DNA DAMAGE; DNA-BINDING PROTEINS; DOXORUBICIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTAGENS; MUTATION; NUCLEAR PROTEINS; ORGANOPLATINUM COMPOUNDS; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 84872590323     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1994     Document Type: Article

References (22)

1. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002;418: 935-41.
2. Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci U S A 2009;106: 2841-6.
3. Lee JH, Sancar A. Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis. Proc Natl Acad Sci U S A 2011;108: 10668-72.
4. Marabese M, Vikhanskaya F, Rainelli C, Sakai T, Broggini M. DNA damage induces transcriptional activation of p73 by removing CEBPalpha repression on E2F1. Nucleic Acids Res 2003;31: 6624-32.
5. Urist M, Tanaka T, Poyurovsky MV, Prives C. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev 2004;18: 3041-54.
6. Seelan RS, Irwin M, van der Stoop P, Qian C, Kaelin WG Jr, Liu W. The human p73 promoter: characterization and identification of functional E2F binding sites. Neoplasia 2002;4: 195-203.
7. Pignatelli M, Luna-Medina R, Perez-Rendon A, Santos A, Perez- Castillo A. The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells. Biochem J 2003;373: 739-46.
8. Yu J, Baron V, Mercola D, Mustelin T, Adamson ED. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells. Cell Death Differ 2007;14: 436-46.
9. Bai L, Zimmer S, Rickes O, Rohleder N, Holthues H, Engel L, et al. Daily oscillation of gene expression in the retina is phase-advanced with respect to the pineal gland. Brain Res 2008;1203: 89-96.
10. Hughes ME, DiTacchio L, Hayes KR, Vollmers C, Pulivarthy S, Baggs JE, et al. Harmonics of circadian gene transcription in mammals. PLoS Genet 2009;5:e1000442.
11. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73: 39-85.
12. Antoch MP, Kondratov RV. Circadian proteins and genotoxic stress response. Circ Res 2010;106: 68-78.
13. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007;7: 573-84.
14. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death.NEngl J Med 2009;361: 1570-83.
15. Lin WC, Lin FT, Nevins Jr. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001;15: 1833-44.
16. Pediconi N, Guerrieri F, Vossio S, Bruno T, Belloni L, Schinzari V, et al. hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage. Mol Cell Biol 2009;29: 1989-98.
17. Carnevale J, Palander O, Seifried LA, Dick FA. DNA damage signals through differentially modified E2F1 molecules to induce apoptosis. Mol Cell Biol 2012;32: 900-12.
18. Biswas AK, Johnson DG. Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res 2012;72: 13-7.
19. Lee JH, Sancar A. Regulation of apoptosis by the circadian clock through NF-kappaB signaling. Proc Natl Acad Sci U S A 2011;108: 12036-41.
20. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-67.
21. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG Jr. Chemosensitivity linked to p73 function. Cancer Cell 2003;3: 403-10.
22. Nevins Jr. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258: 424-9.